• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: This Week in Managed Care—Hospital Readmission and Other Health News

Podcast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included Medicare cuts hospital payments over readmissions; a second-generation chimeric antigen receptor T-cell therapy shows promise; a diabetes drug is approved to prevent kidney failure for the first time.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

What We're Reading: Medicare Issues Readmission Penalties; Virginia Abortion Law Ruling; Vitamin A's Role in Skin Cancer

PwC Report Urges Action to Tackle Social Determinants of Health

Researchers Say Second-Generation CAR T-Cell Therapy Proves Successful in Early Studies, Human Trial Planned

FDA Approves Canagliflozin to Prevent Kidney Failure, Hospitalization for Heart Failure

What We're Reading: DEA Authorized Opioid Production Surge; Georgia Abortion Law Blocked; Drone Deliveries for Healthcare

Patient-Centered Oncology Care—Innovation and Quality: New Directions in Value-Based Care

Read more about the stories in this podcast:

Related Videos
Philip Mease, MD
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Dr Marco del Riccio
Dr Marco del Riccio
Eleanor Perfetto, PhD
Tom Kim, chief medical officer, Sound Long-Term Care Management
Ciara Zachary, PhD, MPH
Related Content
Flat Medicare Advantage payments in 2027 may push higher costs and fewer benefits onto seniors despite CMS reforms. | Image Credit: Postmodern Studio - stock.adobe.com.jpeg

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

January 27th 2026
Article

CMS’s 2027 proposed MA payment rate increase of .09% falls short of expectations, potentially increasing premiums and reducing benefits for seniors.

Read More

managed care cast logo

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

January 27th 2026
Podcast

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Older woman interacts with smart speaker technology | Image credit: Vadim Pastuh - stock.adobe.com

Smart Speaker Improves Mental Health, A1C in Older Adults With Diabetes

January 23rd 2026
Article

A randomized clinical trial found a voice-enabled virtual assistant reduced mental distress and improved quality of life, self-care, and glycemic control.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Red heart with stethoscope. eggeeggjiew | Stethoscope Heart_AdobeStock_188239868.jpe.jpg

Suboptimal Cardiovascular Risk Management Found in Mexican Adults With Diabetes

January 22nd 2026
Article

Few adults with diabetes in Mexico achieve combined CVD risk factor control, highlighting gaps in blood pressure, cholesterol, and glycemic management.

Read More

Diabetes | Image credit: Minerva Studio - stock.adobe.com.jpg

SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs

January 21st 2026
Article

Initiating SGLT2is was linked to lower risks of chronic kidney disease and fewer acute kidney injury events than GLP-1 RAs in metformin-treated type 2 diabetes.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.